• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOVASCULAR LLC ULTIMA ACTIVATOR II REUSABLE DRIVE MECH; CATHETER, EMBOLECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOVASCULAR LLC ULTIMA ACTIVATOR II REUSABLE DRIVE MECH; CATHETER, EMBOLECTOMY Back to Search Results
Model Number ULTIMA ACTIVATOR II REUSABLE DRIVE MECH
Device Problem Corroded (1131)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/29/2021
Event Type  malfunction  
Manufacturer Narrative
Trackwise id # (b)(4).The device has not yet been returned to maquet cardiac surgery for evaluation.We are following up with the customer for the return of the device.A supplemental report will be submitted if the device is received.
 
Event Description
The hospital reported that during preparation for a coronary artery bypass procedure, ultima activator ii reusable drive mech has pitting corrosion / pitting after 7 reprocessing cycles mechanical cleaning is carried out with the product thermosept xtra 0.5% from schülke.No implantation or use on the patient, but pitting / rust after processing in the washer-disinfector.The retractor has been replaced and is in the hospital as a consignment from uwe tausch.
 
Event Description
N/a.
 
Manufacturer Narrative
Corrected section: h-3 device not eval provide code: from "other" to "device evaluation anticipated, but not yet begun." trackwise id # (b)(4).
 
Manufacturer Narrative
Internal complaint number: (b)(4).Analysis of production: (3331/213/67) the device history records review concluded that there were no ncmrs, rework, or deviations documented for the reported lot number.Based on the dhr/lhr review results, it was determined that there is no relation between the manufacturing process and the reported failure.Historical data analysis: (4109/213/67) the review of the historical data indicates that no other similar complaint was reported for the same lot number and reported failure mode.Trend analysis: (4110/213/67) the overall 24 month product complaint trend data for the period sept 2019 through aug 2021 was reviewed.There were no triggers identified for the review period.Communication/interviews: (4111/213/67) communication/interviews were performed to obtain all possible information.Testing of actual/suspected device: (10/13/22) the device was returned to the factory for evaluation on 09/15/2021.An investigation was conducted on 10/13/2021.A visual inspection was conducted.Signs of clinical use and no evidence of blood was observed.The engraved maquet was observed to be a rust color as well as on the engraved # =200501.Based on the returned condition of the device, the reported failure " corroded" was confirmed.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTIMA ACTIVATOR II REUSABLE DRIVE MECH
Type of Device
CATHETER, EMBOLECTOMY
Manufacturer (Section D)
MAQUET CARDIOVASCULAR LLC
45 barbour pond drive
wayne NJ
MDR Report Key12346587
MDR Text Key268916985
Report Number2242352-2021-00681
Device Sequence Number1
Product Code DXE
UDI-Device Identifier00607567700901
UDI-Public00607567700901
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 10/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberULTIMA ACTIVATOR II REUSABLE DRIVE MECH
Device Catalogue NumberC-UA-5001
Device Lot Number25157489
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/15/2021
Initial Date Manufacturer Received 07/29/2021
Initial Date FDA Received08/20/2021
Supplement Dates Manufacturer Received09/15/2021
10/20/2021
Supplement Dates FDA Received10/11/2021
10/20/2021
Patient Sequence Number1
-
-